About us:

UAB Eipha bioscinces was registered in April 2024 in Vilnius, Lithuania. Eipha will provide innovative solutions for patients through biotechnology and microneedle technology. We are committed to providing effective and permanent treatments with our innovative products for especially various skin patients.

Due to our scientific commitment to innovation and treatment, we set our vision in such a way that we can push the boundaries of biotechnology, achieve new treatment solutions through continuous research and development, and support and treat patients worldwide.

Eventually, here are our values:

• Innovation: Our commitment to innovation and finding new treatment solutions is at the heart of everything we do, and we give this commitment to always give importance to innovative ways so that we can bring permanent treatments to patients by going through traditional treatments.
• Quality: Our products will be subject to continuous quality control tests. Also, implementing the quality-by-design basics into our research and development will make it possible to reach the highest quality and constancy.
• Integrity: Our product portfolio optimizes transparency and originality. The raw materials for these products will be sourced from top-grade natural materials that are rooted in nature.
• Collaboration: Our team will consist of professional members who are well-trained in biotechnology. We will always be open to any partnership and collaboration resulting in added value to our products.